Cerebral vasospasm

Cerebral vasospasm refers to the narrowing of the cerebral arteries, which can lead to a decrease in blood flow to the brain. This condition is most commonly associated with subarachnoid hemorrhage (SAH), which is bleeding into the subarachnoid space around the brain. Cerebral vasospasm can lead to ischemic stroke and has significant morbidity and mortality rates. Understanding the pathophysiology, diagnosis, treatment, and outcomes of cerebral vasospasm is crucial for managing patients with this condition.

Pathophysiology

Cerebral vasospasm typically occurs 3 to 14 days following a subarachnoid hemorrhage. The exact mechanism is not fully understood, but it is believed to involve the release of vasoconstrictive substances (such as oxyhemoglobin) from the lysed red blood cells in the subarachnoid space. These substances lead to inflammation and narrowing of the cerebral arteries. Factors such as endothelial damage, inflammation, and changes in the balance of vasoconstrictors and vasodilators are also implicated in the development of vasospasm.

Diagnosis

The diagnosis of cerebral vasospasm involves clinical assessment and imaging studies. Clinically, patients may present with new or worsening neurological deficits. Transcranial Doppler (TCD) ultrasound is a non-invasive method used to measure blood flow velocity in the cerebral arteries, which can indicate vasospasm. Computed tomography angiography (CTA) and Digital subtraction angiography (DSA) are more direct imaging methods that can visualize the narrowing of the arteries.

Treatment

Treatment of cerebral vasospasm focuses on improving cerebral blood flow and preventing ischemic injury. Medical therapies include the use of calcium channel blockers (e.g., nimodipine), which have been shown to improve outcomes by relaxing blood vessels and increasing blood flow. Hypervolemia, Hemodilution, and hypertension (Triple-H therapy) are also used to increase cerebral perfusion. In refractory cases, endovascular treatments such as intra-arterial vasodilator therapy and angioplasty may be considered.

Outcomes

The outcomes of cerebral vasospasm can vary widely. Early detection and treatment are critical for improving prognosis. Without treatment, cerebral vasospasm can lead to cerebral ischemia, infarction, and potentially death. Even with treatment, some patients may experience long-term neurological deficits.

Prevention

Preventing the initial subarachnoid hemorrhage is key to reducing the risk of cerebral vasospasm. This includes managing risk factors for aneurysms and hypertension, as well as avoiding smoking and the use of recreational drugs.

See also

• Subarachnoid hemorrhage
• Ischemic stroke
• Transcranial Doppler
• Aneurysm

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian